Provided by Tiger Fintech (Singapore) Pte. Ltd.

Xenon Pharmaceuticals

38.28
+0.19000.50%
Post-market: 38.280.00000.00%16:00 EDT
Volume:919.75K
Turnover:35.36M
Market Cap:2.93B
PE:-12.72
High:38.96
Open:38.00
Low:37.75
Close:38.09
Loading ...
Nov 07, 2022

Major Issues Report

8-K - Current report
Aug 09, 2022

Major Issues Report

8-K - Current report
Aug 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 23, 2022

Major Issues Report

8-K - Current report
Jun 21, 2022

Major Issues Report

8-K - Current report
Jun 02, 2022

Major Issues Report

8-K - Current report
Jun 02, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 10, 2022

Major Issues Report

8-K - Current report
May 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 22, 2022

Major Issues Report

8-K - Current report
Mar 21, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Mar 10, 2022

Major Issues Report

8-K - Current report
Mar 01, 2022

Major Issues Report

8-K - Current report
Mar 01, 2022

Major Issues Report

8-K - Current report
Mar 01, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals